A comparative study of EPA-enriched ethanolamine plasmalogen and EPA-enriched phosphatidylethanolamine on A42 induced cognitive deficiency in a rat model of Alzheimer's disease

被引:70
作者
Che, Hongxia [1 ]
Li, Qian [1 ]
Zhang, Tiantian [1 ]
Ding, Lin [1 ]
Zhang, Lingyu [1 ]
Shi, Haohao [1 ]
Yanagita, Teruyoshi [2 ]
Xue, Changhu [1 ,3 ]
Chang, Yaoguang [1 ]
Wang, Yuming [1 ,3 ]
机构
[1] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Shandong, Peoples R China
[2] Nishikyushu Univ, Dept Hlth & Nutr Sci, Kanzaki, Japan
[3] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Biol Prod, Qingdao 266237, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
NEURONAL APOPTOSIS; LEARNING-ABILITY; OXIDATIVE STRESS; PHOSPHOLIPIDS; BETA; PROTECT; BRAIN; MICE;
D O I
10.1039/c8fo00643a
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ethanolamine plasmalogen (pPE), a major phospholipid in neuronal membranes, is specifically reduced in postmortem brains from patients with Alzheimer's disease (AD). The purpose of the present study was to compare the effects of EPA-enriched ethanolamine plasmalogen (EPA-pPE) and EPA-enriched phosphatidylethanolamine (EPA-PE) on cognitive deficiency and illustrate the possible underlying mechanisms. SD rats were divided into four groups including the sham group injected with 0.9% saline and three amyloid- (A) infusion groups, A42 group, EPA-pPE group and EPA-PE group. EPA-pPE and EPA-PE were administered by gavage (150 mg kg(-1) day(-1)), respectively, once a day for 26 days. Administration of EPA-pPE exerted better effects than EPA-PE in improving A-induced cognitive deficiency in a rat model of Alzheimer's disease. Further mechanical research indicated that EPA-pPE was superior to EPA-PE in regulating oxidative stress via increasing SOD activity and decreasing MDA level, as well as reducing GSK-3 and tau phosphorylation. Moreover, EPA-PE was more effective than EPA-pPE at inhibiting the protein expressions of Bax and caspase 9. The results of neuro-inflammation and inflammasome activation showed that EPA-pPE exerted more significant effects than EPA-PE in inhibiting the expressions of TNF- and IL-1, and decreasing NLRP3, pro-caspase 1 and caspase 1 levels. EPA-pPE alleviated A-induced neurotoxicity by inhibiting oxidative stress, neuronal injury, apoptosis and neuro-inflammation, which might depend on the vinyl ether linkage at the sn-1 position.
引用
收藏
页码:3008 / 3017
页数:10
相关论文
共 34 条
[1]  
[Anonymous], 1986, The Rat Brain in Stereotaxic Coordinates.
[2]   Marine Omega-3 Phospholipids: Metabolism and Biological Activities [J].
Burri, Lena ;
Hoem, Nils ;
Banni, Sebastiano ;
Berge, Kjetil .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (11) :15401-15419
[3]   Alzheimer Disease [J].
Castellani, Rudy J. ;
Rolston, Raj K. ;
Smith, Mark A. .
DM DISEASE-A-MONTH, 2010, 56 (09) :484-546
[4]   EPA enriched ethanolamine plasmalogens significantly improve cognition of Alzheimer's disease mouse model by suppressing β-amyloid generation [J].
Che, Hongxia ;
Zhou, Miaomiao ;
Zhang, Tiantian ;
Zhang, Lingyu ;
Ding, Lin ;
Yanagita, Teruyoshi ;
Xu, Jie ;
Xue, Changhu ;
Wang, Yuming .
JOURNAL OF FUNCTIONAL FOODS, 2018, 41 :9-18
[5]   Cerebrosides from Sea Cucumber Protect Against Oxidative Stress in SAMP8 Mice and PC12 Cells [J].
Che, Hongxia ;
Du, Lei ;
Cong, Peixu ;
Tao, Suyuan ;
Ding, Ning ;
Wu, Fengjuan ;
Xue, Changhu ;
Xu, Jie ;
Wang, Yuming .
JOURNAL OF MEDICINAL FOOD, 2017, 20 (04) :392-402
[6]  
Conde de la Rosa L., 2015, PHARM RES PERSPECT, V3
[7]   Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms [J].
Dolunay, Abdurrahman ;
Senol, Sefika Pinar ;
Temiz-Resitoglu, Meryem ;
Guden, Demet Sinem ;
Sari, Ayse Nihal ;
Sahan-Firat, Seyhan ;
Tunctan, Bahar .
INFLAMMATION, 2017, 40 (02) :366-386
[8]   Alzheimer disease therapy-moving from amyloid-β to tau [J].
Giacobini, Ezio ;
Gold, Gabriel .
NATURE REVIEWS NEUROLOGY, 2013, 9 (12) :677-686
[9]   DISEASE AND ANATOMIC SPECIFICITY OF ETHANOLAMINE PLASMALOGEN DEFICIENCY IN ALZHEIMERS-DISEASE BRAIN [J].
GINSBERG, L ;
RAFIQUE, S ;
XUEREB, JH ;
RAPOPORT, SI ;
GERSHFELD, NL .
BRAIN RESEARCH, 1995, 698 (1-2) :223-226
[10]   Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry [J].
Han, XL ;
Holtzman, DM ;
McKeel, DW .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (04) :1168-1180